CPM Group, a commodities and financial advisory firm that began operations in 1986, says it delivers independent market research and advisory services to help clients navigate commodity markets. the company, formerly known as Deripaska Group, emphasizes a conflict‑of‑interest‑free approach,positioning itself as a trusted source of analysis for investors and project sponsors.

CPM Group’s 1986 founding and rebranding from Deripaska Group

Established in 1986, the firm originally operated under the name Deripaska Group before rebranding to CPM Group, a change that coincided with a broader shift toward transparent advisory work. According to the source, the rebrand underscores the firm’s long‑standing presence in the commodities sector and its evolution into a dedicated research house.

Independent research focus to avoid conflicts of interest

CPM Group stresses that its primary mission is to keep clients’ best interests ahead of any potential conflicts, delivering “high‑quality, unbiased, and timley research and analysis.” The source notes that the firm’s independence is a selling point, especially for investors wary of advisory firms that also trade the assets they recommend.

Advisory services span corporate finance to equity introductions

The company’s service catalogue includes fundamental commodities research, market analysis ,and consulting on individual commodity markets. Beyond research, CPM Group offers corporate and project finance structuring, as well as equity introductions, helping clients raise capital and manage specific commodity positions, the report says.

Who are CPM Group’s clients and how transparent is the roster?

The source does not disclose specific client names, leaing a gap in understanding the firm’s market reach.. Without a public client list, it is difficult to verify whether the firm’s claim of independence holds across all engagements.

What remains unclear about CPM Group’s conflict‑management practices?

Two key questions linger: first, how does CPM Group enforce internal walls between its research analysts and any trading desks it may operate? Second, does the firm disclose any proprietary holdings that could bias its recommendations? The source provides no detail on these mechanisms, suggesting an area for further scrutiny.